482 related articles for article (PubMed ID: 10548473)
1. A new approach against sugar cataract through aldose reductase inhibitors.
Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
[TBL] [Abstract][Full Text] [Related]
2. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
[TBL] [Abstract][Full Text] [Related]
3. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
Tao RV; Takahashi Y; Kador PF
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
[TBL] [Abstract][Full Text] [Related]
4. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
5. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.
Kador PF; Betts D; Wyman M; Blessing K; Randazzo J
Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
Kim CS; Kim J; Lee YM; Sohn E; Jo K; Kim JS
Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
[TBL] [Abstract][Full Text] [Related]
7. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
Ao S; Kikuchi C; Ono T; Notsu Y
Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
[TBL] [Abstract][Full Text] [Related]
8. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
[TBL] [Abstract][Full Text] [Related]
9. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
Kim J; Kim CS; Sohn E; Lee YM; Kim JS
J Pharm Pharmacol; 2011 Oct; 63(10):1301-8. PubMed ID: 21899546
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
Nagata M; Robison WG
Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
[TBL] [Abstract][Full Text] [Related]
11. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
Sato S; Mori K; Wyman M; Kador PF
Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
[TBL] [Abstract][Full Text] [Related]
13. Effects of a new aldose reductase inhibitor on diabetic complications in rats.
Gervasi GB; Bartoli C; Catalani R; Farina C; Carpita G; Caccia G; Ammannati P
Arzneimittelforschung; 1991 Nov; 41(11):1160-3. PubMed ID: 1810261
[TBL] [Abstract][Full Text] [Related]
14. [Aldose-reductase inhibitors and cataract formation (author's transl)].
Keller G; Leuenberger PM
Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
Sankeshi V; Kumar PA; Naik RR; Sridhar G; Kumar MP; Gopal VV; Raju TN
J Ethnopharmacol; 2013 Aug; 149(1):215-21. PubMed ID: 23827758
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of in utero galactose-induced cataract development by an aldose reductase inhibitor in rat--electron microscopic study.
Teshima R; Taura T; Okamura R
Jpn J Ophthalmol; 1993; 37(2):192-8. PubMed ID: 8230845
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D
Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892
[TBL] [Abstract][Full Text] [Related]
18. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor.
Obrosova I; Faller A; Burgan J; Ostrow E; Williamson JR
Curr Eye Res; 1997 Jan; 16(1):34-43. PubMed ID: 9043821
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic inhibition of aldose reductase.
Kador PF; Sun G; Rait VK; Rodriguez L; Ma Y; Sugiyama K
J Ocul Pharmacol Ther; 2001 Aug; 17(4):373-81. PubMed ID: 11572468
[TBL] [Abstract][Full Text] [Related]
20. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
